Arkansas Legal Resource Navigator

21 U.S.C. § 1702 — Office of National Drug Control Policy

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 1702 — Office of National Drug Control Policy

**(a) Establishment of Office** There is established in the Executive Office of the President an Office of National Drug Control Policy, which shall— (1) lead the national drug control effort, including coordinating with the National Drug Control Program agencies; (2) coordinate and oversee the implementation of the national drug control policy, including the National Drug Control Strategy; (3) assess and certify the adequacy of National Drug Control Programs and the budget for those programs; (4) evaluate the effectiveness of national drug control policy efforts, including the National Drug Control Program Agencies’ 11 So in original. Probably should be “agencies’ ”. programs, by developing and applying specific goals and performance measurements and monitoring the agencies’ program-level spending; (5) identify and respond to emerging drug threats related to illicit drug use; (6) administer the Drug-Free Communities Program, the High Intensity Drug Trafficking Areas Program, and other grant programs directly authorized to be administered by the Office in furtherance of the National Drug Control Strategy; and (7) facilitate broad-scale information sharing and data standardization among Federal, State, and local entities to support the national drug control efforts. **(b) Repealed. Pub. L. 115–271, title VIII, § 8222(1), Oct. 24, 2018, 132 Stat. 4142** **(c) Access by Congress** The location of the Office in the Executive Office of the President shall not be construed as affecting access by Congress, or any committee of the House of Representatives or the Senate, to any— (1) information, document, or study in the possession of, or conducted by or at the direction of the Director; or (2) personnel of the Office. **(d) Office of National Drug Control Policy Gif

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1702

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: a5af4530b5079f543535f68b1743d8e1381826beb7f8ccb29d94d5843a3e70d2. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_5d44078cb4e9fa7df87682b5
Source file: Laws/federal/codes/united-states-code/title-21/section-1702-office-of-national-drug-control-policy--9924d32f2a.md
Pages: Not recorded – Not recorded
Passage SHA-256: 0762b5909a379a5cc33c79a3ee32a6b51ea56b5e0e0df1e424a68ee1bc4d252e

Source location: Title 21, Chapter 22, § 1702; chapter-022-national-drug-control-policy.md

Stored source content

**(a) Establishment of Office** There is established in the Executive Office of the President an Office of National Drug Control Policy, which shall— (1) lead the national drug control effort, including coordinating with the National Drug Control Program agencies; (2) coordinate and oversee the implementation of the national drug control policy, including the National Drug Control Strategy; (3) assess and certify the adequacy of National Drug Control Programs and the budget for those programs; (4) evaluate the effectiveness of national drug control policy efforts, including the National Drug Control Program Agencies’ 11 So in original. Probably should be “agencies’ ”. programs, by developing and applying specific goals and performance measurements and monitoring the agencies’ program-level spending; (5) identify and respond to emerging drug threats related to illicit drug use; (6) administer the Drug-Free Communities Program, the High Intensity Drug Trafficking Areas Program, and other grant programs directly authorized to be administered by the Office in furtherance of the National Drug Control Strategy; and (7) facilitate broad-scale information sharing and data standardization among Federal, State, and local entities to support the national drug control efforts. **(b) Repealed. Pub. L. 115–271, title VIII, § 8222(1), Oct. 24, 2018, 132 Stat. 4142** **(c) Access by Congress** The location of the Office in the Executive Office of the President shall not be construed as affecting access by Congress, or any committee of the House of Representatives or the Senate, to any— (1) information, document, or study in the possession of, or conducted by or at the direction of the Director; or (2) personnel of the Office. **(d) Office of National Drug Control Policy Gift Fund** (1) **Establishment** — There is established in the Treasury of the United States a fund for the receipt of gifts, both real and personal, for the purpose of aiding or facilitating the work of the Office under [section 1703(c) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1703/c&num=0&edition=prelim). (2) **Contributions** — The Office may accept, hold, and administer contributions to the Fund. (3) **Use of amounts deposited** — Amounts deposited in the Fund are authorized to be appropriated, to remain available until expended for authorized purposes at the discretion of the Director. (4) **Ethics guidelines** — The Director shall establish written guidelines setting forth the criteria to be used in determining whether a gift or donation should be declined under this subsection because the acceptance of the gift or donation would— (A) reflect unfavorably upon the ability of the Director or the Office, or any employee of the Office, to carry out responsibilities or official duties under this chapter in a fair and objective manner; or (B) compromise the integrity or the appearance of integrity of programs or services provided under this chapter or of any official involved in those programs or services. (5) **Registry of gifts** — The Director shall maintain a list of— (A) the source and amount of each gift or donation accepted by the Office; and (B) the source and amount of each gift or donation accepted by a contractor to be used in its performance of a contract for the Office. (6) **Report to Congress** — The Director shall include in the annual assessment under [section 1705(g) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1705/g&num=0&edition=prelim) a copy of the registry maintained under paragraph (5).

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 1712 — Repealed. Pub. L. 115–271, title VIII, § 8202(b)(2), Oct. 24, 2018, 132 Stat. 4110

### Statutory Notes Section, Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), Oct. 24, 2018, 132 Stat. 4110, provided for the termination of Office of National Drug Control Policy and repealed this chapter effective Sept. 30, 2010.

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1712

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 1701 — Definitions

In this chapter: (1) **Agency** — The term “agency” has the meaning given the term “executive agency” in [section 102 of title 31](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section102&num=0&edition=prelim). (2) **Appropriate congressional committees** (A) *In general* — The term “appropriate congressional committees” means— (i) the Committee on the Judiciary, the Committee on Appropriations, and the Committee on Health, Education, Labor, and Pensions of the Senate; and (ii) the Committee on Oversight and Government Reform, the Committee on the Judiciary, the Committee on Energy and Commerce, and the Committee on Appropriations of the House of Representatives. (B) *Submission to Congress* — Any submission to Congress shall mean submission to the appropriate congressional committees. (3) **Demand reduction** — The term “demand reduction” means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce or prevent the use of drugs or support, expand, or provide treatment and recovery efforts, including— (A) education about the dangers of illicit drug use; (B) services, programs, or strategies to prevent substance use disorder, including evidence-based education campaigns, community-based prevention programs, collection and disposal of unused prescription drugs, and services to at-risk populations to prevent or delay initial use of an illicit drug; (C) substance use disorder treatment; (D) support for long-term recovery from substance use disorders; (E) drug-free workplace programs; (F) drug testing, including the testing of employees; (G) interventions for illicit drug use and dependence; (H) expanding availability of access to health c

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1701

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 1501, 1502 — Repealed. Pub. L. 100–690, title I, § 1009, Nov. 18, 1988, 102 Stat. 4188, as amended by Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234

### Statutory Notes Section 1501, Pub. L. 100–690, title I, § 1002, Nov. 18, 1988, 102 Stat. 4181, established Office of National Drug Control Policy in Executive Office of President. See [section 1702 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1702&num=0&edition=prelim). Section 1502, Pub. L. 100–690, title I, § 1003, Nov. 18, 1988, 102 Stat. 4182; Pub. L. 103–322, title IX, §§ 90201, 90202, 90207, Sept. 13, 1994, 108 Stat. 1990, 1991, 1995, related to appointment and duties of Director, Deputy Directors, and Associate Director of Office of National Drug Control Policy. See [section 1703 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1703&num=0&edition=prelim). #### Effective Date of Repeal Repeal effective Sept. 30, 1997, see section 1009 of Pub. L. 100–690, as amended, which was formerly classified to [section 1506 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1506&num=0&edition=prelim). #### Short Title of 1997 Amendment Pub. L. 105–20, § 1, June 27, 1997, 111 Stat. 224, provided that: “This Act [enacting subchapter II of this chapter and amending former sections 1504, 1506 to 1508 of this title, [section 2291 of Title 22](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title22-section2291&num=0&edition=prelim), Foreign Relations and Intercourse, and provisions set out as notes under this section] may be cited as the ‘Drug-Free Communities Act of 1997’.” #### Short Title Pub. L. 100–690, § 1, Nov. 18, 1988, 102 Stat. 4181, provided that: “This Act [see Tables for classification] may be cited as the ‘Anti-Drug Abuse Act of 1988’.” Pub. L. 100–690, title I, § 1001, Nov. 18, 1988, 102 Stat. 4181, provided that: “Thi

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1501, 1502

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 1702 — Office of National Drug Control Policy

Page 960 TITLE 21—FOOD AND DRUGS § 1702 1 So in original. Probably should be ‘‘agencies’ ’’. 1999 found that in just 1 year’s time the rate of steroid use among young people rose roughly 50 percent among both sexes and across all age groups. It is the policy of my Administration to take the steps needed to help eliminate illicit or otherwise banned drug use and doping in sports at the State, national, and inter- national level. SEC. 2. Establishment of a White House Task Force on Drug Use in Sports. (a) There is established a White House Task Force on Drug Use in Sports (Task Force). The Task Force shall comprise the co-vice chairs of the White House Olympic Task Force (the ‘‘Olympic Task Force Vice Chairs’’), and representatives designated by the Office of National Drug Control Policy, the Depart- ment of Health and Human Services, the Department of Labor, the President’s Council on Physical Fitness and Sports [now President’s Council on Fitness, Sports, and Nutrition], the Office of Management and Budget, the National Security Council, the Department of State, the Department of the Treasury, the Department of Education, the Department of Justice, the Department of Transportation, the Department of Homeland Secu- rity, the National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Adminis- tration. (b) The Task Force shall develop recommendations for the President on further executive and legislative actions that can be undertaken to address the problem of doping and drug use in sports. In developing the rec- ommendations, the Task Force shall consider, among other things: (i) the health and safety of America’s ath- letes, in particular our Nation’s young people; (ii) the integrity of honest athletic competition; and

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 1702

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.